间质性肺疾病与结节病。
Interstitial Lung Disease and Sarcoidosis.
机构信息
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA.
出版信息
Clin Chest Med. 2023 Sep;44(3):575-584. doi: 10.1016/j.ccm.2023.06.003.
Interstitial lung disease (ILD), a clinically recognized group of diseases resulting in pulmonary fibrosis, affects up to 200 individuals per 100,000 in the United States. Sarcoidosis has a wide range of clinical manifestations including pulmonary fibrosis. Health disparities are prevalent in both ILD and sarcoidosis around socioeconomic status, race, gender, and geographic location. This review outlines the known health disparities, discusses possible determinants of disparities, and outlines a path to achieve equity in ILD and sarcoidosis.
间质性肺疾病（ILD）是一组临床公认的疾病，可导致肺纤维化，在美国每 10 万人中就有多达 200 人患病。结节病的临床表现广泛，包括肺纤维化。ILD 和结节病在社会经济地位、种族、性别和地理位置等方面都存在健康差异。本综述概述了已知的健康差异，讨论了差异的可能决定因素，并概述了实现ILD 和结节病公平的途径。
Zotero 插件